music.apple.com/jp/album/kem...
music.apple.com/jp/album/kem...
Thanks to Charles Nyaigoti & James Abuje for being great hosts and showing us the fantastic science they are doing.
@cvrinfo.bsky.social
@davidlrobertson.bsky.social
🇰🇪🦠🔬🧬
Thanks to Charles Nyaigoti & James Abuje for being great hosts and showing us the fantastic science they are doing.
@cvrinfo.bsky.social
@davidlrobertson.bsky.social
🇰🇪🦠🔬🧬
Find out more 👉 buff.ly/j0PtDCb
Find out more 👉 buff.ly/j0PtDCb
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/profess...
Read more 👉 www.tropicalmedicine.ox.ac.uk/news/profess...
The Observatory will improve our understanding of mosquito-borne diseases in Africa.
@drheatherferg.bsky.social
Read more www.gla.ac.uk/news/headlin...
In the last 20 years, we have delivered 13 treatments for six deadly diseases & we continue to serve neglected populations. #EndTheNeglect
In the last 20 years, we have delivered 13 treatments for six deadly diseases & we continue to serve neglected populations. #EndTheNeglect
Apply here : shorturl.at/2sRFS
Apply here : shorturl.at/2sRFS
Read more 👉 buff.ly/0OU6UhJ
Read more 👉 buff.ly/0OU6UhJ
Great to be part of this workshop on December 2025, 3D printing weather station components and adapting open blueprints from SEACO HDSS in Malaysia for local use in Kenya.
Low-cost technology and collaboration across teams.
#ClimateAndHealth #GlobalHealth
Great to be part of this workshop on December 2025, 3D printing weather station components and adapting open blueprints from SEACO HDSS in Malaysia for local use in Kenya.
Low-cost technology and collaboration across teams.
#ClimateAndHealth #GlobalHealth
www.saltandcaramel.com/living-hiv-p...
www.saltandcaramel.com/living-hiv-p...
Ivermektin, 5 ila 15 yaş arası çocuklarda yeni sıtma enfeksiyonlarında yüzde 26'lık bir azalmaya yol açtı.
Ivermektin, 5 ila 15 yaş arası çocuklarda yeni sıtma enfeksiyonlarında yüzde 26'lık bir azalmaya yol açtı.
On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)
On July 8, 2025, the clinical trials team at the KEMRI Wellcome Trust Research Programme began vaccinating volunteers with the ChAdOx1 RVF vaccine candidate in Kilifi, Kenya, as part of a Phase II trial. 🧵 (1/8)
⬇️
👉https://www.gla.ac.uk/news/headline_1206540_en.html
#mosquitoes #mosquitobornediseases #onehealth
⬇️
Discover more about the success of the first cohort
👉 www.liverpool.ac.uk/research/new...
Discover more about the success of the first cohort
👉 www.liverpool.ac.uk/research/new...
The abstract submission deadline for #ISSAD2026 is now October 19, 2025.
Here: issad.org/abstract-sub...
#ISSAD2026 #FromEvidencetoAction #GBS #KEMRI
The abstract submission deadline for #ISSAD2026 is now October 19, 2025.
Here: issad.org/abstract-sub...
#ISSAD2026 #FromEvidencetoAction #GBS #KEMRI
Find out more 👉 buff.ly/E3JLtpV
Find out more 👉 buff.ly/E3JLtpV
Great teamwork bringing 3D-printed weather station components to KEMRI, Kisumu.
#ClimateAndHealth #GlobalHealth #3DPrinting
One of the weather station components being printed during our workshop at KEMRI, Kisumu, Kenya 🇰🇪.
#3DPrinting #ClimateAndHealth #GlobalHealth
Great teamwork bringing 3D-printed weather station components to KEMRI, Kisumu.
#ClimateAndHealth #GlobalHealth #3DPrinting